Cite
HARVARD Citation
Takei, Y. et al. (2017). Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimens. Journal of obstetrics and gynaecology research. 43 (2), pp. 358-364. [Online].